HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The combination of tephrosin with 2-deoxy-D-glucose enhances the cytotoxicity via accelerating ATP depletion and blunting autophagy in human cancer cells.

Abstract
2-Deoxy-D-glucose (2-DG), a synthetic glucose analog that acts as a glycolytic inhibitor, is currently under clinical evaluation for targeting tumor cells. Tephrosin (TSN), a plant rotenoid, is known as an anticancer agent. In this study, we describe that the addition of TSN to 2-DG enhanced the cytotoxic activity of 2-DG against various types of cancer cells by accelerating ATP depletion and blunting autophagy. TSN increased the sensitivity of cancer cells to the cytotoxic effect of 2-DG. The combination of TSN and 2-DG induced acceleration of intracellular ATP depletion and the drastic activation of AMP-activated protein kinase (AMPK), which resulted in the inactivation of the mammalian target of rapamycin (mTOR) pathway. Of particular interest, TSN suppressed 2-DG-induced autophagy, a cell survival process in response to nutrient deprivation. We also showed that TSN inhibited 2-DG-induced activation of elongation factor-2 kinase (eEF-2K), which has been known to regulate 2-DG-induced autophagy. Inhibition of eEF-2K by RNA interference blunted 2-DG-induced autophagy and increased the sensitivity of cancer cells to the cytotoxic effect of 2-DG. The addition of TSN to 2-DG, however, did not enhance the cytotoxic activity of 2-DG by knockdown of eEF-2K, suggesting that inhibition of eEF-2K by tephrsoin could be a critical role in the potentiating effect of TSN on the cytotoxicity of 2-DG. Furthermore, we showed that the blunted autophagy and enhanced cytotoxicity of 2-DG was accompanied by the augmentation of apoptosis. These results show that TSN may be valuable for augmenting the therapeutic efficacy of 2-DG.
AuthorsYunjin Choi, Jeong-Hyung Lee
JournalCancer biology & therapy (Cancer Biol Ther) Vol. 12 Issue 11 Pg. 989-96 (Dec 01 2011) ISSN: 1555-8576 [Electronic] United States
PMID22123175 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Rotenone
  • tephrosin
  • Adenosine Triphosphate
  • Deoxyglucose
  • Elongation Factor 2 Kinase
Topics
  • Adenosine Triphosphate (metabolism)
  • Antineoplastic Combined Chemotherapy Protocols (toxicity)
  • Apoptosis (drug effects)
  • Autophagy (drug effects)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Deoxyglucose (toxicity)
  • Elongation Factor 2 Kinase (metabolism)
  • Enzyme Activation (drug effects)
  • Humans
  • Intracellular Space (drug effects, metabolism)
  • Neoplasms (metabolism)
  • Rotenone (analogs & derivatives, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: